These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 30657558)

  • 21. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells.
    Zheng H; Wang JJ; Yang XR; Yu YL
    World J Gastroenterol; 2020 Feb; 26(5):499-513. PubMed ID: 32089626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-124 changes the sensitivity of lung cancer cells to cisplatin through targeting STAT3.
    Qi MM; Ge F; Chen XJ; Tang C; Ma J
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5242-5250. PubMed ID: 31298375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R and BCL2.
    Wang T; Ge G; Ding Y; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
    Chin Med J (Engl); 2014; 127(12):2357-62. PubMed ID: 24931256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lidocaine alleviates cisplatin resistance and inhibits migration of MGC-803/DDP cells through decreasing miR-10b.
    Zhang X; Gu G; Li X; Zhang C
    Cell Cycle; 2020 Oct; 19(19):2530-2537. PubMed ID: 32892697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells.
    Xu X; Jiang X; Chen L; Zhao Y; Huang Z; Zhou H; Shi M
    Cancer Biother Radiopharm; 2019 Nov; 34(9):559-565. PubMed ID: 31436472
    [No Abstract]   [Full Text] [Related]  

  • 26. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Gu Y; Fei Z; Zhu R
    Anticancer Drugs; 2020 Apr; 31(4):385-393. PubMed ID: 31913198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells.
    Yang X; Cai H; Liang Y; Chen L; Wang X; Si R; Qu K; Jiang Z; Ma B; Miao C; Li J; Wang B; Gao P
    Oncol Rep; 2015 Apr; 33(4):1723-30. PubMed ID: 25633261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted regulation of miR-195 on MAP2K1 for suppressing ADM drug resistance in prostate cancer cells.
    Zhang JY; Li YN; Mu X; Pan ZL; Liu WB
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8599-8608. PubMed ID: 30575899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-132 reverses cisplatin resistance and metastasis in ovarian cancer by the targeted regulation on Bmi-1.
    Zhang XL; Sun BL; Tian SX; Li L; Zhao YC; Shi PP
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3635-3644. PubMed ID: 31114988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosomal microRNA-588 from M2 polarized macrophages contributes to cisplatin resistance of gastric cancer cells.
    Cui HY; Rong JS; Chen J; Guo J; Zhu JQ; Ruan M; Zuo RR; Zhang SS; Qi JM; Zhang BH
    World J Gastroenterol; 2021 Sep; 27(36):6079-6092. PubMed ID: 34629821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1.
    Li X; Liang J; Liu YX; Wang Y; Yang XH; Luan BH; Zhang GL; Du J; Wu XH
    Pharmazie; 2016 Nov; 71(11):640-643. PubMed ID: 29441968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA DANCR accelerates the development of multidrug resistance of gastric cancer.
    Xu YD; Shang J; Li M; Zhang YY
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2794-2802. PubMed ID: 31002130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of circBIRC6 targeting miR-367-3p on cisplatin resistance of ovarian cancer cells].
    Zhang J; Bai HJ
    Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1062-1068. PubMed ID: 34695896
    [No Abstract]   [Full Text] [Related]  

  • 34. MiR-155 targeting FoxO3a regulates oral cancer cell proliferation, apoptosis, and DDP resistance through targeting FoxO3a.
    Li X; Liu K; Zhou W; Jiang Z
    Cancer Biomark; 2020; 27(1):105-111. PubMed ID: 31771044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR‑138‑5p modulates the expression of excision repair cross‑complementing proteins ERCC1 and ERCC4, and regulates the sensitivity of gastric cancer cells to cisplatin.
    Ning J; Jiao Y; Xie X; Deng X; Zhang Y; Yang Y; Zhao C; Wang H; Gu K
    Oncol Rep; 2019 Feb; 41(2):1131-1139. PubMed ID: 30535472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7.
    Zhou X; Jin W; Jia H; Yan J; Zhang G
    J Exp Clin Cancer Res; 2015 Mar; 34(1):28. PubMed ID: 25888377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The reversing and molecular mechanisms of miR-503 on the drug-resistance to cisplatin in A549/DDP cells].
    Wu Y; Guo L; Liu J; Liu R; Liu M; Chen J
    Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):1-7. PubMed ID: 24398307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of miR-144 on proliferation, apoptosis and cisplatin resistance by targeting MYCN in pediatric neuroblastoma].
    Liu HJ; Li GL; Lei PC
    Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):516-521. PubMed ID: 31357838
    [No Abstract]   [Full Text] [Related]  

  • 39. MicroRNA-101 induces apoptosis in cisplatin-resistant gastric cancer cells by targeting VEGF-C.
    Li G; Yang F; Gu S; Li Z; Xue M
    Mol Med Rep; 2016 Jan; 13(1):572-8. PubMed ID: 26573417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.
    Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J
    Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.